Page Changed: Diabetes Drugs - Quick Summary
Updated information for incretin drugs Byetta, Bydureon, Januvia, Janumet, Onlglyza, Kombiglyze, Trajenta, Jentadueto, and Victoza to include doubled risk of pancreatitis and abnormal cell overgrowth associated with adenomas and tumors.
Added information about Invokana, the new SGLT2 inhibitor.
Changed rating of all incretin drugs to ---- due to convincing evidence that they cause dangerous cell changes in the pancreas.
Monday, April 1, 2013
Subscribe to:
Posts (Atom)
